BBR Partners »

Lenz Therapeutics shares owned by BBR Partners

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by BBR Partners from 13F filings

Historical chart of BBR Partners investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by BBR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by BBR Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $346k 20k 17.29

More positions owned by BBR Partners

Spdr S&p 500 Etf (SPY)
iShares S&P 500 Index (IVV)
United Parcel Service (UPS)
Apple (AAPL)
Vanguard S&p 500 Etf idx (VOO)
Microsoft Corporation (MSFT)
Kkr & Co (KKR)
Vanguard Total Stock Market ETF (VTI)
Invesco S&p 500 Equal Weight Etf (RSP)
Vanguard Information Technology ETF (VGT)
Alphabet Inc Class A cs (GOOGL)
Philip Morris International (PM)
Abbvie (ABBV)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway (BRK.B)

View all positions for BBR Partners

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
Point72 Asset Management
Tang Capital Management
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Ikarian Capital
Board of Trustees of The Leland Stanford Junior University
Wealth Enhancement Advisory Services

View all funds holding Lenz Therapeutics